These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34462158)

  • 1. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
    Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
    Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between human leukocyte antigen alleles and COVID-19 disease severity.
    Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
    J Infect Public Health; 2024 Sep; 17(9):102498. PubMed ID: 39173558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I associations with the severity of COVID-19 disease in the United Arab Emirates.
    Tay GK; Alnaqbi H; Chehadeh S; Peramo B; Mustafa F; Rizvi TA; Mahboub BH; Uddin M; Alkaabi N; Alefishat E; Jelinek HF; Alsafar H;
    PLoS One; 2023; 18(9):e0285712. PubMed ID: 37708194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
    Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
    Front Immunol; 2020; 11():605688. PubMed ID: 33343579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
    Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
    J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
    Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA alleles associated with susceptibility and severity of the COVID-19 in Vietnamese.
    Hai NTT; Nhung VP; Tam NTT; Ngoc TTB; Thuong MTH; Dai HV; Duong NT; Hai NV; Ton ND; Thach PN; Ha NH
    Hum Immunol; 2024 May; 85(3):110796. PubMed ID: 38580537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19.
    Korkmaz FN; Gökçay Canpolat A; Dalva K; Şahin M; Çorapçıoğlu D; Demir Ö
    Hum Immunol; 2024 Jul; 85(4):110834. PubMed ID: 38936012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing.
    Marzouka NAD; Alnaqbi H; Al-Aamri A; Tay G; Alsafar H
    Sci Rep; 2024 Feb; 14(1):3392. PubMed ID: 38337023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B*15 predicts survival in Egyptian patients with COVID-19.
    Abdelhafiz AS; Ali A; Fouda MA; Sayed DM; Kamel MM; Kamal LM; Khalil MA; Bakry RM
    Hum Immunol; 2022 Jan; 83(1):10-16. PubMed ID: 34607724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients.
    Ebrahimi S; Ghasemi-Basir HR; Majzoobi MM; Rasouli-Saravani A; Hajilooi M; Solgi G
    Hum Immunol; 2021 Oct; 82(10):719-725. PubMed ID: 34294460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.
    Saulle I; Vicentini C; Clerici M; Biasin M
    Hum Immunol; 2021 Aug; 82(8):551-560. PubMed ID: 34116863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
    Iturrieta-Zuazo I; Rita CG; García-Soidán A; de Malet Pintos-Fonseca A; Alonso-Alarcón N; Pariente-Rodríguez R; Tejeda-Velarde A; Serrano-Villar S; Castañer-Alabau JL; Nieto-Gañán I
    Clin Immunol; 2020 Oct; 219():108572. PubMed ID: 32810602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.
    Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
    Virology; 2021 Aug; 560():1-7. PubMed ID: 34015620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity.
    Hovhannisyan A; Madelian V; Avagyan S; Nazaretyan M; Hyussyan A; Sirunyan A; Arakelyan R; Manukyan Z; Yepiskoposyan L; Mayilyan KR; Jordan F
    Front Immunol; 2022; 13():769900. PubMed ID: 35185875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; López-Ruz MÁ; Martín-Casares AM; Fernández-Rubiales A; Anderson P; Garrido F; Ruiz-Cabello F; López-Nevot MÁ
    J Microbiol Immunol Infect; 2022 Jun; 55(3):421-427. PubMed ID: 34475005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID-19.
    Tao S; You X; Norman PJ; Kichula KM; Dong L; Chen N; He J; Zhang W; Zhu F
    HLA; 2024 Oct; 104(4):e15715. PubMed ID: 39364548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.
    Amoroso A; Magistroni P; Vespasiano F; Bella A; Bellino S; Puoti F; Alizzi S; Vaisitti T; Boros S; Grossi PA; Trapani S; Lombardini L; Pezzotti P; Deaglio S; Brusaferro S; Cardillo M;
    Transplantation; 2021 Jan; 105(1):193-200. PubMed ID: 33141807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
    Marchal A; Cirulli ET; Neveux I; Bellos E; Thwaites RS; Schiabor Barrett KM; Zhang Y; Nemes-Bokun I; Kalinova M; Catchpole A; Tangye SG; Spaan AN; Lack JB; Ghosn J; Burdet C; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Dalgard CL; Zhang SY; Zhang Q; Chiu C; Fellay J; Grzymski JJ; Sancho-Shimizu V; Abel L; Casanova JL; Cobat A; Bolze A
    HGG Adv; 2024 Jul; 5(3):100300. PubMed ID: 38678364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients.
    Novelli A; Andreani M; Biancolella M; Liberatoscioli L; Passarelli C; Colona VL; Rogliani P; Leonardis F; Campana A; Carsetti R; Andreoni M; Bernardini S; Novelli G; Locatelli F
    HLA; 2020 Nov; 96(5):610-614. PubMed ID: 32827207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.